ID   OGA_RAT                 Reviewed;         916 AA.
AC   Q8VIJ5;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   02-OCT-2024, entry version 135.
DE   RecName: Full=Protein O-GlcNAcase {ECO:0000303|PubMed:8034696, ECO:0000303|Ref.1, ECO:0000305};
DE            Short=OGA;
DE            EC=3.2.1.169 {ECO:0000269|PubMed:8034696};
DE   AltName: Full=Beta-N-acetylhexosaminidase;
DE   AltName: Full=Beta-hexosaminidase;
DE   AltName: Full=Bifunctional protein NCOAT {ECO:0000303|PubMed:15485860};
DE   AltName: Full=Meningioma-expressed antigen 5;
DE   AltName: Full=N-acetyl-beta-D-glucosaminidase;
DE   AltName: Full=N-acetyl-beta-glucosaminidase;
GN   Name=Oga {ECO:0000312|RGD:621077}; Synonyms=Hexc, Mea5, Mgea5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=Fischer 344;
RA   Liu K., Paterson A.J., Van Tine B.A., Konrad R.J., Parlow A.F., Jimi S.,
RA   Chin E. Jr., Kudlow J.E.;
RT   "The O-GlcNAcase gene is a candidate for diabetes susceptibility in GK
RT   rats.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   BIOPHYSICOCHEMICAL PROPERTIES, FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, ACTIVITY REGULATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Spleen;
RX   PubMed=8034696; DOI=10.1016/s0021-9258(17)32170-1;
RA   Dong D.-L., Hart G.W.;
RT   "Purification and characterization of an O-GlcNAc selective N-acetyl-beta-
RT   D-glucosaminidase from rat spleen cytosol.";
RL   J. Biol. Chem. 269:19321-19330(1994).
RN   [3]
RP   IDENTIFICATION OF ISOFORMS 2 AND 3.
RC   STRAIN=GK, and Sprague-Dawley;
RX   PubMed=15485860; DOI=10.1074/jbc.m410406200;
RA   Toleman C., Paterson A.J., Whisenhunt T.R., Kudlow J.E.;
RT   "Characterization of the histone acetyltransferase (HAT) domain of a
RT   bifunctional protein with activable O-GlcNAcase and HAT activities.";
RL   J. Biol. Chem. 279:53665-53673(2004).
RN   [4]
RP   FUNCTION OF ISOFORMS 2 AND 3, AND LACK OF CATALYTIC ACTIVITY OF ISOFORMS 2
RP   AND 3.
RX   PubMed=16517082; DOI=10.1016/j.bbagen.2006.01.017;
RA   Toleman C., Paterson A.J., Kudlow J.E.;
RT   "Location and characterization of the O-GlcNAcase active site.";
RL   Biochim. Biophys. Acta 1760:829-839(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: [Isoform 1]: Cleaves GlcNAc but not GalNAc from O-
CC       glycosylated proteins (PubMed:8034696). Deglycosylates a large and
CC       diverse number of proteins, such as CRYAB, ELK1, GSDMD, LMNB1 and TAB1
CC       (By similarity). Can use p-nitrophenyl-beta-GlcNAc and 4-
CC       methylumbelliferone-GlcNAc as substrates but not p-nitrophenyl-beta-
CC       GalNAc or p-nitrophenyl-alpha-GlcNAc (in vitro) (PubMed:8034696). Does
CC       not bind acetyl-CoA and does not have histone acetyltransferase
CC       activity (By similarity). {ECO:0000250|UniProtKB:O60502,
CC       ECO:0000269|PubMed:8034696}.
CC   -!- FUNCTION: [Isoform 2]: Lacks enzyme activity.
CC       {ECO:0000269|PubMed:16517082}.
CC   -!- FUNCTION: [Isoform 3]: Lacks enzyme activity.
CC       {ECO:0000269|PubMed:16517082}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-(N-acetyl-beta-D-glucosaminyl)-L-seryl-[protein] + H2O =
CC         L-seryl-[protein] + N-acetyl-D-glucosamine; Xref=Rhea:RHEA:48876,
CC         Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:12251, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:29999, ChEBI:CHEBI:90838, ChEBI:CHEBI:506227;
CC         EC=3.2.1.169; Evidence={ECO:0000269|PubMed:8034696};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-(N-acetyl-beta-D-glucosaminyl)-L-threonyl-[protein] + H2O
CC         = L-threonyl-[protein] + N-acetyl-D-glucosamine;
CC         Xref=Rhea:RHEA:48892, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:12252,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:90840,
CC         ChEBI:CHEBI:506227; EC=3.2.1.169;
CC         Evidence={ECO:0000269|PubMed:8034696};
CC   -!- ACTIVITY REGULATION: Inhibited by Cu(2+), Hg(2+), Cd(2+) and Zn(2+) at
CC       1 mM. Not inhibited by Co(2+), Mg(2+), Ca(2+), Mn(2+), Fe(3+) and EDTA.
CC       Also inhibited by sodium chloride at 1M and 2-amino-2-hydroxymethyl-
CC       1,3-propanediol (trishydroxymethylaminomethane) at 75 mM.
CC       {ECO:0000269|PubMed:8034696}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.55 mM for pNP-O-GlcNAc {ECO:0000269|PubMed:8034696};
CC       pH dependence:
CC         Optimum pH is 6.4. Activity decreases sharply at pH below 5.0.
CC         {ECO:0000269|PubMed:8034696};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius. Less active at room
CC         temperature and shows very little activity at 4 degrees Celsius.
CC         Loses activity at 57 degrees Celsius within 5 minutes.
CC         {ECO:0000269|PubMed:8034696};
CC   -!- SUBUNIT: Monomer. Interacts with CLOCK (By similarity).
CC       {ECO:0000250|UniProtKB:O60502, ECO:0000250|UniProtKB:Q9EQQ9}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:8034696}. Cytoplasm
CC       {ECO:0000269|PubMed:8034696}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8VIJ5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8VIJ5-2; Sequence=VSP_020873;
CC       Name=3;
CC         IsoId=Q8VIJ5-3; Sequence=VSP_020874;
CC   -!- TISSUE SPECIFICITY: Detected in spleen (at protein level). Ubiquitous.
CC       Expressed at highest levels in the brain and spleen.
CC       {ECO:0000269|PubMed:8034696}.
CC   -!- PTM: Proteolytically cleaved by caspase-3 during apoptosis. The
CC       fragments interact with each other; cleavage does not decrease enzyme
CC       activity. {ECO:0000250|UniProtKB:O60502}.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 84 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01353, ECO:0000305}.
CC   -!- CAUTION: Was initially identified as a bi-functional protein that has
CC       an N-terminal domain with O-GlcNAcase activity and a C-terminal domain
CC       that has histone acetyltransferase activity (PubMed:15485860). The
CC       protein has apparent histone acetyltransferase activity when expressed
CC       in mammalian cells, but not when expressed in bacterial cells
CC       (PubMed:15485860), suggesting that the histone acetyltransferase
CC       activity might be due to the presence of a contaminant.
CC       Characterization of the human ortholog shows that this protein does not
CC       bind acetyl-CoA and therefore cannot have acetyltransferase activity.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY039679; AAK72103.1; -; mRNA.
DR   RefSeq; NP_571979.1; NM_131904.1. [Q8VIJ5-1]
DR   AlphaFoldDB; Q8VIJ5; -.
DR   SMR; Q8VIJ5; -.
DR   STRING; 10116.ENSRNOP00000059568; -.
DR   BindingDB; Q8VIJ5; -.
DR   ChEMBL; CHEMBL3351213; -.
DR   GuidetoPHARMACOLOGY; 3101; -.
DR   CAZy; GH84; Glycoside Hydrolase Family 84.
DR   GlyGen; Q8VIJ5; 2 sites, 1 O-linked glycan (2 sites).
DR   iPTMnet; Q8VIJ5; -.
DR   PhosphoSitePlus; Q8VIJ5; -.
DR   jPOST; Q8VIJ5; -.
DR   PaxDb; 10116-ENSRNOP00000059568; -.
DR   Ensembl; ENSRNOT00060041092; ENSRNOP00060034021; ENSRNOG00060023694. [Q8VIJ5-1]
DR   Ensembl; ENSRNOT00065051150; ENSRNOP00065042091; ENSRNOG00065029612. [Q8VIJ5-1]
DR   GeneID; 154968; -.
DR   KEGG; rno:154968; -.
DR   UCSC; RGD:621077; rat. [Q8VIJ5-1]
DR   AGR; RGD:621077; -.
DR   CTD; 10724; -.
DR   RGD; 621077; Oga.
DR   eggNOG; KOG3698; Eukaryota.
DR   HOGENOM; CLU_009837_1_0_1; -.
DR   InParanoid; Q8VIJ5; -.
DR   OrthoDB; 2903353at2759; -.
DR   PhylomeDB; Q8VIJ5; -.
DR   PRO; PR:Q8VIJ5; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0102571; F:[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity; ISO:RGD.
DR   GO; GO:0016231; F:beta-N-acetylglucosaminidase activity; IDA:RGD.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IMP:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0046060; P:dATP metabolic process; IMP:RGD.
DR   GO; GO:0009100; P:glycoprotein metabolic process; IBA:GO_Central.
DR   GO; GO:0006044; P:N-acetylglucosamine metabolic process; IMP:RGD.
DR   GO; GO:0010616; P:negative regulation of cardiac muscle adaptation; IMP:RGD.
DR   GO; GO:0060051; P:negative regulation of protein glycosylation; IMP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:0051928; P:positive regulation of calcium ion transport; IMP:RGD.
DR   GO; GO:0010524; P:positive regulation of calcium ion transport into cytosol; IMP:RGD.
DR   GO; GO:0031343; P:positive regulation of cell killing; IMP:RGD.
DR   GO; GO:0051054; P:positive regulation of DNA metabolic process; IMP:RGD.
DR   GO; GO:0046326; P:positive regulation of glucose import; IMP:RGD.
DR   GO; GO:0060124; P:positive regulation of growth hormone secretion; IMP:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:RGD.
DR   GO; GO:0051901; P:positive regulation of mitochondrial depolarization; IMP:RGD.
DR   GO; GO:0043243; P:positive regulation of protein-containing complex disassembly; IMP:RGD.
DR   GO; GO:0045862; P:positive regulation of proteolysis; IMP:RGD.
DR   GO; GO:0006612; P:protein targeting to membrane; IMP:RGD.
DR   GO; GO:0048545; P:response to steroid hormone; IEP:RGD.
DR   Gene3D; 3.40.630.30; -; 1.
DR   Gene3D; 3.20.20.80; Glycosidases; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR051822; Glycosyl_Hydrolase_84.
DR   InterPro; IPR011496; O-GlcNAcase_cat.
DR   PANTHER; PTHR13170; O-GLCNACASE; 1.
DR   PANTHER; PTHR13170:SF16; PROTEIN O-GLCNACASE; 1.
DR   Pfam; PF07555; NAGidase; 1.
DR   SUPFAM; SSF51445; (Trans)glycosidases; 1.
DR   SUPFAM; SSF55729; Acyl-CoA N-acyltransferases (Nat); 1.
DR   PROSITE; PS52009; GH84; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Glycosidase; Hydrolase; Nucleus;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..916
FT                   /note="Protein O-GlcNAcase"
FT                   /id="PRO_0000252120"
FT   DOMAIN          60..336
FT                   /note="GH84"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01353"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          440..480
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        450..480
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        175
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01353"
FT   BINDING         67
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   BINDING         98
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   BINDING         174
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   BINDING         219
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   BINDING         278..280
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   BINDING         285
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   BINDING         313
FT                   /ligand="a protein"
FT                   /ligand_id="ChEBI:CHEBI:16541"
FT                   /evidence="ECO:0000250|UniProtKB:Q0TR53"
FT   SITE            413..414
FT                   /note="Cleavage; by caspase-3"
FT                   /evidence="ECO:0000250|UniProtKB:O60502"
FT   MOD_RES         364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         250..398
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020873"
FT   VAR_SEQ         250..345
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_020874"
SQ   SEQUENCE   916 AA;  102918 MW;  4BA1746F0AF2E380 CRC64;
     MVQKESQAAL EERESERNAN PASVSGASLE PSAAPAPGED NPSGAGAAAG TGAAGGARRF
     LCGVVEGFYG RPWVMEQRKE LFRRLQKWEL NTYLYAPKDD YKHRMFWREM YSVEEAEQLM
     TLISAAREYE IEFIYAISPG LDITFSNPKE VSTLKRKLDQ VSQFGCRSFA LLFDDIDHNM
     CAADKEVFSS FAHAQVSITN EIYQYLGEPE TFLFCPTEYC GTFCYPSVSQ SPYLRTVGEK
     LLPGIEVLWT GPKVVSKEIP VESIEEVSKI IKRAPVIWDN IHANDYDQKR LFLGPYKGRS
     TELIPRLKGV LTNPNCEFEA NYVAIHTLAT WYKSNMNGVR KDVVMTDSED STVSIQIKLE
     NEGSDEDIET DVLYSPQMAL KLALTEWLQE FGVPHQYSSR QVAHSGAKTS VVDGTPLVAA
     PSLNATTVVT TVYQEPIMSQ GAALSGEPSA LTKEEEKKQP DEEPMDMVVE KQEESEHKSD
     NQILTEIVEA KMAEELKPMD TDKESIAESK SPEMSMQEDC INDIAPMQTD EQANKEQFVP
     GPNEKPLYAA EPVTLEDLQL LADLFYLPYE HGPKGAQMLR EFQWLRANSS VVSVNCKGKD
     SEKIEEWRSR AAKFEEMCAL VMGMFTRLSN CANRTILYDM YSYVWDIKSI MSMVKSFVQW
     LGCRSHSSAQ FLIGDQEPWA FRGGLAGEFQ RLLPIDGAND LFFQPPPLTP TSKVYTIRPY
     FPKDEASVYK ICREMYDDGV GLPFQSQPDL IGDKLVGGLL SLSLDYCFVL EDEDGICGYA
     LGTVDVTPFI KKCKISWIPF MQEKYTKPNG DKELSEAEKI MLSFHEEQEV LPETFLANFP
     SLIKMDIHKK VTDPSVAKSM MACLLSSLKA NGSRGAFCEV RPDDKRILEF YSKLGCFEIA
     KMEGFPKDVV ILGRSL
//
